$1.92
-0.03 (-1.54%)
Analyst Consensus
Buy
14
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,009.4% upside
Low Target
$14.71
Average Target
$21.30
High Target
$34.17
Current Price
$1.92
Current
$1.92
$1.92
Target
$21.30
$21.30
$14.71
$21.30 avg
$34.17
Scenario Analysis
Bear Case
$14.71
666.1%
Low target
Base Case
$21.30
+1,009.4%
Avg target
Bull Case
$34.17
+1,679.7%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$3.40
-43.5% from high
52-Week Low
$1.09
+76.1% from low
Target vs 52W High
$21.30
+526.5% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -3.3% |
| AMGN | Hold | 43 | 47% | $190.87 | -54.4% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +138.3% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -16.9% |
| REGN | Buy | 38 | 68% | $76.80 | -89.8% |
| MRNA | Hold | 30 | 37% | $149.45 | -24.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -65.3% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -43.4% |